{"title":"SARS-CoV-2组粒变异诱导的交叉保护性免疫","authors":"Selia Chowdhury , Md. Shahraj Chowdhury , Nurjahan Shipa Chowdhury , Samia Chowdhury , Shajeda Chowdhury","doi":"10.1016/j.clicom.2023.07.007","DOIUrl":null,"url":null,"abstract":"<div><p>The newly discovered SARS-CoV-2 Omicron (B.1.1.529) variant is the most antigenically unique SARS-CoV-2 variant of concern to date, which is presently prevalent across most of the world. According to a number of studies, the Omicron variant causes a restricted immune response after infection. A critical component of study is determining the efficacy of Omicron-induced immunity and if it is cross-protective against other variants.</p></div>","PeriodicalId":100269,"journal":{"name":"Clinical Immunology Communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cross-protective immunity induced by omicron variant of SARS-CoV-2\",\"authors\":\"Selia Chowdhury , Md. Shahraj Chowdhury , Nurjahan Shipa Chowdhury , Samia Chowdhury , Shajeda Chowdhury\",\"doi\":\"10.1016/j.clicom.2023.07.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The newly discovered SARS-CoV-2 Omicron (B.1.1.529) variant is the most antigenically unique SARS-CoV-2 variant of concern to date, which is presently prevalent across most of the world. According to a number of studies, the Omicron variant causes a restricted immune response after infection. A critical component of study is determining the efficacy of Omicron-induced immunity and if it is cross-protective against other variants.</p></div>\",\"PeriodicalId\":100269,\"journal\":{\"name\":\"Clinical Immunology Communications\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Immunology Communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772613423000215\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Immunology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772613423000215","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Cross-protective immunity induced by omicron variant of SARS-CoV-2
The newly discovered SARS-CoV-2 Omicron (B.1.1.529) variant is the most antigenically unique SARS-CoV-2 variant of concern to date, which is presently prevalent across most of the world. According to a number of studies, the Omicron variant causes a restricted immune response after infection. A critical component of study is determining the efficacy of Omicron-induced immunity and if it is cross-protective against other variants.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
